Results 101 to 110 of about 60,448 (331)
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2015 Aim of investigation. To estimate advantages of combined intake of proton pump inhibitor (PPI) and alginate in comparison to monotherapy by PPI in terms of symptom relief in the first days of gastroesophageal reflux disease (GERD) treatment.Material and ...
D. S. Bordin +3 more
doaj
Gastroesophageal reflux disease associated with diseases of the respiratory tract
Acta Biomedica Scientifica, 2018 The European community of gastroenterologists in 1997 recognized GERB as "illness of the 21st century". Diseases of a respiratory tract take the leading place among all extra esophageal implications of a gastroesophageal reflux disease.
S. O. Fedorova, N. M. Kozlova
doaj +1 more source
Specific Subjective Symptoms for Gastroesophageal Reflux Disease in Ulcer Like Dyspepsia [PDF]
, 2004 Background: The Aim of study is to identify specific subjective symptoms for gastroesophageal reflux disease (GERD), GERD proportion in ulcer like dyspepsia and the correlation between specific subjective symptoms for GERD and endoscopic examination ...
Andrijani, P. K. (Poerniati) +3 more
core +1 more source
Neurogastroenterology &Motility, EarlyView.The novel manometric parameter Milan Score could be useful in predicting which patients with type 2 EGJ have a high likelihood of objective GERD, therefore discriminating which patients may need escalation of GERD investigation and management. ABSTRACT Introduction High‐resolution manometry (HRM) allows assessment of esophagogastric junction (EGJ ...
Davide Ferrari +29 more
wiley +1 more source
Akram’s lifestyle: An effective remedy for the management of gastroesophageal reflux disease
Journal of Family and Community MedicineINTRODUCTION: The prevalence of gastroesophageal reflux disease (GERD) has generally increased worldwide. Irregular pattern of intake of meals are known to be the most prevalent cause of GERD.
Sadia A. Khan +5 more
doaj +1 more source
Neurogastroenterology &Motility, EarlyView.DGBI symptoms are common in obesity and have the potential to exacerbate negative health outcomes. In general, the prevalence of DGBI symptoms decreases after obesity treatment, but patients can also shift from one GI symptom profile to another. ABSTRACT Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes.
Esther Colomier +11 more
wiley +1 more source
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome
Neurogastroenterology &Motility, EarlyView.ABSTRACT Background Exposure to COVID‐19 has been shown previously to be associated with a higher risk for irritable bowel syndrome (IBS). This study aimed to better explain this relationship using mediation analysis. Methods This post hoc analysis of a multicenter cohort study includes 623 patients with and without COVID‐19 infection. All participants
Keren Hod +68 more
wiley +1 more source
Esophageal striated muscle contractions in patients with Chagas' disease and idiopathic achalasia
Brazilian Journal of Medical and Biological Research, 2002 Chagas' disease causes degeneration and reduction of the number of intrinsic neurons of the esophageal myenteric plexus, with consequent absent or partial lower esophageal sphincter relaxation and loss of peristalsis in the esophageal body.
R.O. Dantas +3 more
doaj +1 more source
Neurogastroenterology &Motility, EarlyView.Current treatments often fall short in managing IBS effectively. Silicolgel, an enterosorbent, reduced IBS and other gastrointestinal symptoms in 90% of IBS patients compared to 20% in those on placebo. Enterosorbents are not currently recommended for IBS; silicolgel is a widely available, affordable option for patients with IBS‐D and IBS‐M.
O. Kuzminska +3 more
wiley +1 more source